Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced the treatment of the first patient in the ARTIZEN pivotal trial, evaluating the ...
In a groundbreaking medical achievement, a Turkish cardiovascular surgeon, Prof Ugursay Kiziltepe, led and supervised a ...
Cardiovascular disease due to atherosclerosis is the leading cause of disease and mortality worldwide. So-called “vulnerable” atherosclerotic plaques are those that are likely to result in clinical ...
The National Institute of Cardiovascular Diseases (NICVD), Karachi, has made medical history by successfully performing a highly complex ...
Endovascular Stent Grafts Market to Reach $1.76 billion by 2032, Driven by Aging Populations and Advances in Device Durability Request for customizatio The global Endovascular Stent Grafts ...
Intermountain Health surgeons have achieved a medical milestone for Utah patients by successfully performing the state’s first minimally invasive ascending ...
Aortic endografts are minimally invasive medical devices used in the treatment of aortic aneurysms, particularly abdominal and thoracic aortic aneurysms. These grafts are delivered via catheter-based ...
In performing open arch replacement, surgeons at our center and others currently prefer to reattach the individual brachiocephalic branches separately, rather than reattaching a single island of ...
Fred Alger Management, an investment management company, released its “Alger Weatherbie Specialized Growth Fund” ...
14don MSN
Minimally invasive procedure for aortic valve disease has similar outcomes as surgery, study reports
People who underwent a minimally invasive procedure to have their heart's aortic valve replaced had similar health outcomes years after treatment as people who had surgery, Cedars-Sinai investigators ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback